RenovoRx (RNXT) Deferred Taxes (2024)
RenovoRx's (RNXT) quarterly Deferred Taxes came in at $128000.0 in Q2 2024, up 574.07% quarter-over-quarter from -$27000.0 in Q1 2024.
Powered by 
Analysis
RenovoRx (RNXT) Deferred Taxes (2024) Analysis & Trends
RenovoRx has disclosed Deferred Taxes across 1 years of filings, most recently posting $128000.0 for Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | -31.00 Mn |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | 127.00 Mn |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 107.00 Mn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 17.00 Mn |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | -181.30 Mn |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | -300,000.00 |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 600,000.00 |
| 10 | RenovoRx | 82.06 Mn | 82.06 Mn | 766,000.00 | - |